Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Bélanger S, Martin G. Évaluation économique du diagnostic moléculaire du virus influenza. [Economic evaluation of the molecular diagnosis of the influenza virus] Quebec: Institut national d'excellence en sante et en services sociaux (INESSS). 2016 Authors' conclusions Introducing rapid RT-PCR, in replacement of RDTs and the traditional RT-PCR technique, to diagnose influenza could make tests self-financing and would product substantial savings. However, such a conclusion can be influenced by several factors, such as the prevalence of influenza, the age of the target population and the technology used (including the number and cost of analyses). These factors limit the scope of the conclusion which therefore can in no way be generalized. Indexing Status Subject indexing assigned by CRD MeSH Cost-Benefit Analysis; Humans; Influenza A virus; Influenza, Human Country of organisation Canada English summary An English language summary is available. Address for correspondence Institut national d'excellence en santé et en services sociaux (INESSS), 1195 avenue Lavigerie, bureau 60 Québec (Québec) Canada, G1V 4N3
Email: inesss@inesss.qc.ca AccessionNumber 32017000016 Date abstract record published 03/01/2017 |